OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	208
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	199
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	138
Tacrolimus-induced Parkinsonism	98
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	92
The DeMyers: Marian (1922–2012) and William (1924–2008)	89
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	88
Richard Caton (1842-1926)	80
Tourette syndrome: effects of acetyl-leucine in two individuals	79
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	78
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	76
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	75
Complications of reversible cerebral vasoconstriction syndrome in relation to age	75
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	71
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	70
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	68
Explaining recovery from coma with multimodal neuroimaging	67
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	66
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	64
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	62
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	60
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	60
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	59
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	58
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	56

Perceptual response characterization in acute vestibular implant stimulation	56
Comprehensive effects of Parkinson’s disease multimodal complex treatment (PD-MCT): a two-center prospective trial	56
Effects of deep brain stimulation on non-motor symptoms in Parkinson’s disease: insights from longitudinal studies using consistent evaluation scales	55
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	54
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	51
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	51
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	50
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	50
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	50
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	49
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	49
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	48
Longitudinal predictors of health-related quality of life in isolated dystonia	48
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	48
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	47
International survey on the implementation of the European and American guidelines on disorders of consciousness	47
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	47
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	46
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	46
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	46
Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI	45
Neurological manifestation of HEV infection: still a rare disease entity?	45
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	45